These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10627474)

  • 21. Stem cell factor directly stimulates the development of enriched granulocyte-macrophage colony-forming cells and promotes the effects of other colony-stimulating factors.
    Heyworth CM; Whetton AD; Nicholls S; Zsebo K; Dexter TM
    Blood; 1992 Nov; 80(9):2230-6. PubMed ID: 1384798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in methylcellulose in myeloproliferative disorders.
    Siitonen T; Zheng A; Savolainen ER; Koistinen P
    Eur J Haematol; 1995 Oct; 55(4):228-34. PubMed ID: 7589339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia.
    Peters DG; Hoover RR; Gerlach MJ; Koh EY; Zhang H; Choe K; Kirschmeier P; Bishop WR; Daley GQ
    Blood; 2001 Mar; 97(5):1404-12. PubMed ID: 11222387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.
    Kochetkova M; Iversen PO; Lopez AF; Shannon MF
    J Clin Invest; 1997 Jun; 99(12):3000-8. PubMed ID: 9185524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nf1 and Gmcsf interact in myeloid leukemogenesis.
    Birnbaum RA; O'Marcaigh A; Wardak Z; Zhang YY; Dranoff G; Jacks T; Clapp DW; Shannon KM
    Mol Cell; 2000 Jan; 5(1):189-95. PubMed ID: 10678181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of CFU-GM (colony forming units for granulocytes and macrophages) from intact and pinealectomized rat bone marrow to murine recombinant interleukin-3 (rIl-3), recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and human recombinant erythropoietin (rEPO).
    Haldar C; Häussler D; Gupta D
    Prog Brain Res; 1992; 91():323-5. PubMed ID: 1410417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor specific ribozyme in juvenile myelomonocytic leukemic cells.
    Iversen PO; Sioud M
    Blood; 1998 Dec; 92(11):4263-8. PubMed ID: 9834232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts.
    Sun J; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1998 Mar; 16(11):1467-73. PubMed ID: 9525745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay.
    Tanaka M; Takahashi Y; Xu Y; Yoshida N; Yoshimi A; Villalobos IB; Hama A; Nishio N; Hidaka H; Wang Y; Yagasaki H; Kojima S
    Leuk Res; 2008 Jul; 32(7):1036-42. PubMed ID: 18164384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti tumor activity of farnesyl transferase inhibitor].
    Yoshimatsu K; Nagasu T
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):145-55. PubMed ID: 9030225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma stimulates the survival and influences the development of bipotential granulocyte-macrophage colony-forming cells.
    Kan O; Heyworth CM; Dexter TM; Maudsley PJ; Cook N; Vallance SJ; Whetton AD
    Blood; 1991 Nov; 78(10):2588-94. PubMed ID: 1824254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.
    Nakazawa Y; Matsuda K; Kurata T; Sueki A; Tanaka M; Sakashita K; Imai C; Wilson MH; Koike K
    J Hematol Oncol; 2016 Mar; 9():27. PubMed ID: 26983639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S; Pettit GR; McCrady C
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Bender JG; Unverzagt KL; Maples PB; Mehrotra Y; Mellon J; Van Epps DE; Stewart CC
    Exp Hematol; 1992 Oct; 20(9):1135-40. PubMed ID: 1361455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment.
    Leoncini PP; Bertaina A; Papaioannou D; Flotho C; Masetti R; Bresolin S; Menna G; Santoro N; Zecca M; Basso G; Nigita G; Veneziano D; Pagotto S; D'Ovidio K; Rota R; Dorrance A; Croce CM; Niemeyer C; Locatelli F; Garzon R
    Oncotarget; 2016 Aug; 7(34):55395-55408. PubMed ID: 27447965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of macrophages in the regulation of erythroid colony growth in vitro.
    Wang CQ; Udupa KB; Lipschitz DA
    Blood; 1992 Oct; 80(7):1702-9. PubMed ID: 1391939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.
    Barak Y; Hahn T; Pecht M; Karov Y; Berrebi A; Zaizov R; Stark B; Buchner V; Burstein Y; Trainin N
    Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.